Secondary haemophagocytic lymphohistiocytosis is a rare occurrence amongst cancer patients with COVID-19
Br J Haematol
.
2021 Feb;192(3):e87-e90.
doi: 10.1111/bjh.17275.
Epub 2020 Dec 16.
Authors
Thomas Hueso
1
2
,
Clémentine Bouchez
3
,
Flore Salviat
4
,
Stéphanie Foulon
4
,
Laurence Albiges
3
,
Arnaud Bayle
3
,
Emmanuelle Gallois
5
,
Véronique Vergé
5
,
Valérie Boige
3
,
Franck Griscelli
5
,
Fanny Pommeret
3
,
David Ghez
1
Affiliations
1
Hematology Department, Gustave Roussy Cancer Centre, Villejuif, France.
2
Paris-Sud University, Paris-Saclay University, Le Kremlin-Bicêtre, France.
3
Oncology Department, Gustave Roussy Cancer Centre, Villejuif, France.
4
Biostatistics Department, Gustave Roussy Cancer Centre, Villejuif, France.
5
Biology Department, Gustave Roussy Cancer Centre, Villejuif, France.
PMID:
33326597
DOI:
10.1111/bjh.17275
No abstract available
Publication types
Letter
MeSH terms
COVID-19 / complications*
COVID-19 / diagnosis
Humans
Lymphohistiocytosis, Hemophagocytic / diagnosis*
Lymphohistiocytosis, Hemophagocytic / etiology*
Neoplasms / complications*
Neoplasms / diagnosis
SARS-CoV-2*